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Abstract 
Objective: The aim of this study is to analyze subjectively, using the SWAL-QOL questionnaire, swallowing dys-
function and associated factors after treatment with radiotherapy and chemotherapy in patients treated for head and 
neck cancer. 
Material and Methods: This is a cross-sectional study, based on the selection of patients with tumors of the head and 
neck area, treated with radiotherapy with or without chemotherapy during the years 2000 to 2006 at the Oncology 
Institute of Juiz de Fora. The data were analyzed using SPSS 15.0 software, and were evaluated using the chi-
square test to compare differences in proportions between groups. The statistical significance level was set at 5%.
Results: It was observed that with respect to foods of solid consistency, there was a statistically significant differen-
ce for mouth tumors (p<0.01), with a tendency in this group to use softer foods, easier to chew (stews, boiled vege-
tables, creamy soups, canned fruit). With reference to the domains of the SWAL-QOL, the location of the tumor in 
the mouth was statistically associated with the lowest quality of life in the symptoms domain (p<0.05). The female 
gender variable was associated with the lowest perceived quality of life in several domains, namely swallowing 
(p=0.02); fatigue (p=0.008); symptoms (p=0.009). Age (split below and above 60 years) was not associated with 
differences in perceived quality of life in any domain. 
Conclusion: Tumor in the mouth and the total dose of radiation in the superior fossa were associated with the lowest 
quality of life in the symptoms domain. The female gender variable was associated with the lowest perceived quali-
ty of life in several domains This study shows that speech therapy should maintain a presence in the teams, to then 
guide the rehabilitation of organic dysphonia and mechanical dysphagia possibly afflicting patients after cancer 
treatment with radiation therapy and chemotherapy.
Key words: Quality of life, dysphagia, head and neck neoplasms, rehabilitation.
Campos RJDSd, Palma PV, Leite ICG. Quality of life in patients with 
dysphagia after radiation and chemotherapy treatment for head and neck 
tumors. J Clin Exp Dent. 2013;5(3):e122-7.
http://www.medicinaoral.com/odo/volumenes/v5i3/jcedv5i3p122.pdf
Article Number: 51092                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Scopus
DOI® System
doi:10.4317/jced.51092
http://dx.doi.org/10.4317/jced.51092
e123
J Clin Exp Dent. 2013;5(3):e122-7. Quality of life in patients with dysphagia after cancer treatment
Introduction
Treatment for head and neck cancer aims to cure the dis-
ease, along with good functional results in both speech 
and swallowing (1). The preferred method of treatment 
varies depending on the tumor site, size, and presence 
or absence of regional lymph nodes. The combination 
of radiotherapy and chemotherapy promotes preserva-
tion of the structures maintaining proper function, and 
it turns out that since the 1980s, the number of articles 
published in which authors claim that organ preserva-
tion, in many cases, may be equivalent to the preserva-
tion of function, is becoming ever greater.
Functional results of the combination of radiotherapy 
and chemotherapy for tumors in the head and neck area 
can preserve the organ and work to maintain function-
ality (2-6). However, radiotherapy can cause other dis-
orders in different degrees of severity, notably: edema 
and fibrosis of the exposed region, trismus, mucositis, 
xerostomia, odynophagia, actinic dermatitis, substan-
tial weight loss, and the need to use alternative feeding 
routes (7).
Impairment in the efficiency of swallowing or in the 
safety of swallowing may afflict patients treated with or-
gan preserving procedures, which may exhibit different 
consequences depending on the changes occurring in 
the treatment due to anatomical and functional changes 
(8,9).
The SWAL-QOL is an important tool for assessing the 
patient’s point of view on the effectiveness of rehabilita-
tion, as regards the impact of impairment of swallowing 
on quality of life (10,11).
This work is justified by the importance of the occurren-
ce of swallowing problems after radiotherapy and / or 
chemotherapy treatment for cancer of the head and neck. 
These significant impairments in patients’ oral commu-
nication interfere with their quality of life. Moreover, 
treatment directed at these vocal disorders is low cost 
and provides significant improvement in the quality of 
life and voice of these patients.
Material and Methods
The study was conducted in the city of Juiz de Fora, lo-
cated in the Zona da Mata region in southeastern Minas 
Gerais, and identified as the fourth most populous muni-
cipality in the state. It is the main industrial, cultural, and 
educational center of the Zona da Mata of Minas Gerais, 
especially in relation to health care, and can be conside-
red a major hub for health services in the region.
The study sample was designed in the form of a cross-
sectional study, based on the selection of cases diagnosed 
and treated in the Radiotherapy Section of the Oncology 
Institute of Juiz de Fora, from the hospital records of the 
institution. It was approved by the Ethics Committee on 
Human Research of PROPESQ / UFJF under protocol 
no. 236/2007.
The inclusion criteria for patient admission of in the stu-
dy were patients with tumors of the oral cavity, pharynx, 
and larynx, diagnosed and treated in the aforementioned 
hospital, in the period from 2000 to 2006, with stage T1, 
T2, T3, or T4 (in the latter case, for patients who refused 
surgical treatment); and with a proposed treatment of ra-
diotherapy, exclusively or concomitant with chemothe-
rapy, with a curative intent, through cervicofacial fields, 
augmented or not from the supraclavicular fossa field, 
or a proposed palliative therapy; and also patients who 
did speech therapy prior to, during, or after such medical 
treatments. The exclusion criteria were patients that had 
died during the study period; patients who underwent 
surgical treatment in the head and neck area due to can-
cer, combined or not with other procedures; a progressi-
ve history of neurological disorders, due to possible in-
terference in larynx physiology; as well as impairments 
of a physical, motor, and / or emotional nature that pre-
vented the patient from participating in the study. They 
were diagnosed in oncology. All treatment was done in 
another institution which may influence the quality of 
life and differentiate them from other patients.
Out of 698 patients identified as receiving care between 
2000 and 2006 for the treatment of tumors of the oral 
cavity, pharynx and larynx, 394 were excluded from the 
study because hospital records showed surgical treatment 
for cancer, and 304 patients, who had undergone radio-
therapy and / or chemotherapy for the treatment of head 
and neck cancer, were included in the study. Following 
hospital records analysis and sample identification, con-
tacts were made by phone and it was determined that 
79 patients had died; 150 had outdated records, making 
contact impossible; 35 had undergone salvage surgery; 2 
had undergone chemotherapy only; 7 patients refused to 
participate in the research; and 6 were not treated at the 
Institute. So, ultimately, 25 patients were evaluated.
The 25 patients were located by the Speech Therapy 
Service of the Oncology Institute of Juiz de Fora, and 
invited to participate in the research. After they signed 
free and informed consent statements, their research 
questionnaire responses and voice measurements were 
taken.
The study method consisted of applying the Quality of 
Life in Swallowing Disorders (SWAL-QOL) question-
naire to patients after treatment with radiotherapy and / 
or chemotherapy for head and neck tumors, independent 
of swallowing dysfunction complaints (12), and vali-
dated in Portuguese (13). SWAL-QOL is divided into 
44 questions that assess eleven domains, those being: 
swallowing as a burden, desire to eat, meal duration, 
frequency of symptoms, food selection, communication, 
fear of eating, mental health, social life, sleep, and fati-
gue.
The data were analyzed with SPSS 15.0 software, and 
were evaluated using the chi-square test, to compare 
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differences in proportions between the analysis groups 
(according to anatomic location, gender, therapeutic in-
tervention standard). For continuous variables, means 
were analyzed using the Student’s t-test. The comparison 
of ordinal variables (quality of life and voice quality sca-
les) with nominal outcomes (type of treatment, gender, 
tumor location) was performed using the Kruskal-Wallis 
test. The statistical significance level was set at 5%.
Results
From the sample, 54% of the group were aged between 
51 and 69 years. The self-reported skin color was white 
in 72% of the cases. Gender was male in 72% of the 
cases. The predominant education level was “up to 8 
years” in 56% of the patients.
As for the tumor and treatment characteristics (Table 1) 
we observed 60% of the tumors were laryngeal, stage II 
being the most common, accounting for 32%. The thera-
peutic procedure used most often was radiotherapy and 
chemotherapy.
At the time of the interview, none of the patients were 
making use of feeding tubes and consuming liquid food 
in any consistency exclusively. Regarding the consis-
tency of solid foods, there was a statistically significant 
difference for mouth tumors (p<0.01), with a tendency 
in this group to use softer foods, easier to chew (stews, 
boiled vegetables, creamy soups, canned fruit).
With reference to the SWAL-QOL domains, the location 
of the tumor in the mouth was statistically associated 
with the lowest quality of life in the symptoms domain 
(p<0.05). The total dose of radiation in the superior fossa 
above 5000 Gy also stood out in the symptoms domain 
with a worse score (p=0.08), and total radiation recei-
ved above 7000 Gy was associated with worse scores in 
the sleep domain (p=0.008). The female gender variable 
was associated with the lowest perceived quality of life 
in several domains, namely swallowing (p=0.02); fati-
gue (p=0.008); symptoms (p=0.009). Age (split below 
and above 60 years) was not associated with differences 
in perceived of quality of life in any domain.
In the health self-assessment, there were no differences 
in relation to anatomical location, nor gender.
Table 2 and Table 3 show the SWAL-QOL results obser-
ved in the patients studied.
Table 1. Characteristics of the tumor and treatment implemented and sociodemographic profile of patients with cancer of the head and 
neck treated using organ-preserving procedures, Brazil, 2011.
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Table 2. Mean scores for the SWAL-QOL domeins, from patients with head and neck cancer treated using organ-preserving proce-
dures, Brazil, 2011.
Table 3. Mean scores and standard deviations for the SWAL-SOL domains, according to anatomical location of the tumor, Brazil, 
2011.
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Discussion
The SWAL-QOL questionnaire is described as an im-
portant tool for researchers to assess quality of life and 
dysphagia. It consists of direct and practical questions 
that evaluate the quality of life of patients, who for any 
given treatment, exhibit dysphagia as a consequence 
(12).
A study on patients after treatment for nasopharyn-
geal carcinoma was developed using the University of 
Washington (UW-QOL) questionnaire and the SWAL-
QOL. As a result, 43 patients self-reported difficulty 
in swallowing. The study concluded that swallowing 
difficulty could negatively influence the quality of life 
of patients after treatment for nasopharyngeal carcino-
ma, and that the application of a specific questionnaire 
to measure this problem, such as SWAL-QOL, is beco-
ming necessary, as well as more research in this area to 
determine parameters for delivering better treatment to 
patients (14).
A study aiming to describe the quality of life related to 
swallowing, in patients treated for tongue cancer, was 
developed, with 29 patients participating in the study. 
Patients with an advanced disease level, who underwent 
radiation therapy for tumor treatment, had worse sco-
res on most of the domains, such as problems chewing, 
pleasure in eating, among others (15).
The feasibility, reliability, and validity of the SWAL-
QOL questionnaire was evaluated, and as a result ob-
tained high reliability, good feasibility, and except for 
patients with a feeding tube, validity for patients with 
swallowing problems. The group suggests further com-
parative studies by applying this questionnaire for di-
fferent tumor locations, and as an instrument capable of 
identifying the need for speech rehabilitation therapy 
among patients who present difficulty in swallowing 
(16).
The SWAL-QOL questionnaire for assessing quality of 
life was validated for the French language, results be-
ing collected from patients after surgical treatment of 
tumors of the oropharynx, and patients that had suffered 
a stroke. The French version is considered understanda-
ble and acceptable by patients, helping to evaluate the 
quality of life of patients with oropharyngeal dysphagia, 
and contributing to their referral for speech rehabilita-
tion therapy (17).
Quality of life is an important measure of health status 
and the effects of therapy in patients with oropharyngeal 
dysphagia. The validity of the SWAL-QOL was evalua-
ted, and in this study singled out as the gold standard or 
reference, when compared with two other questionnaires 
that measure quality of life (18). The SWAL-QOL ques-
tionnaire obtained a high level of patient acceptance, 
with excellent psychometric properties, in a study on its 
validation for the Swedish language (19).
The aftermath of this medical treatment turns out directly 
affecting oral communication, voice, and swallowing for 
the patients treated, thus speech therapy should maintain 
a presence in the teams, to then guide the rehabilitation 
of organic dysphonia and mechanical dysphagia possi-
bly afflicting patients after cancer treatment with radio-
therapy and chemotherapy.
Speech therapy is aimed at training and at rehabilitation 
of oral communication, voice, and swallowing disorders 
that can afflict patients after radiotherapy and chemo-
therapy for head and neck cancers. The oncological re-
habilitation, proposed by the speech therapist, restores 
the functions of speech, voice, and swallowing in pa-
tients who have undergone treatment for head and neck 
tumors. It is becoming important to publish research that 
determines the disorders most common for these pa-
tients, and their impact on patient quality of life, so that 
techniques can be established that enable a better res-
toration of these functions that directly affect the daily 
life of the patient.
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